Categories AlphaGraphs, Earnings, Health Care

Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results

Teva Pharmaceuticals’ (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue of $4.4 billion. Wall Street expected Teva to earn $0.59 per share on revenue of $4.15 billion. TEVA stock surged about 7% in the pre-market trading session.

Teva Pharmaceuticals (TEVA) Q1 2020 Earnings Infograph

GAAP net income attributable to ordinary shareholders was $69 million or $0.06 per share in the first quarter of 2020, compared to GAAP net loss of $105 million or $0.10 per share in the first quarter of 2019.

[irp posts=”53332″]

The Tel Aviv, Israel-based company confirmed its outlook for fiscal 2020. EPS is expected to be between $2.30 and $2.55, while revenue is targeted to be in the range of $16.6 billion to $17 billion for fiscal 2020.

Most Popular

Adobe Inc. (ADBE) Stock: Should you invest in this recession-proof tech firm?

Adobe, Inc. (NASDAQ: ADBE) has been dominating the design software space for quite some time, all along staying resilient to macroeconomic fluctuations and market headwinds. The company’s cloud-based applications, offered

Brilliant Earth IPO: Here are a few points to note about this jewelry company that goes public next week

Jewelry has always played a significant role in people’s lives. As life begins to go back to normal after the pandemic and people start attending social events, they are looking

Kontrol Technologies CEO Paul Ghezzi: Our focus is on reinvesting for growth

Tell us about BioCloud, how it’s different from any alternate existing products, and your distribution model. BioCloud exists as a part of Kontrol Technologies and is an innovation within our

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top